The US Food and Drug Administration will review evidence about the safety and efficacy of mifepristone, one of the drugs used ...

Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family ...

Conservatives have criticized the abortion medication, particularly after it became available through telehealth.

Now that most abortions are chemical rather than surgical, pro-life advocates have amped up pressure on lawmakers and ...

An FDA review of mifepristone is sparking concern over politics outweighing science, even as the agency approved a new ...

The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’ ...

Attorney General Nick Brown, along with 19 other attorneys general, has issued a joint statement affirming the safety and ...

The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...

The Food and Drug Administration has launched a new transparency policy for the reporting of foodborne illness outbreak ...

WASHINGTON (AP) — Shortly before he was forced to resign, the nation’s top vaccine regulator says he refused to grant Health Secretary Robert F. Kennedy Jr.’s team unrestricted access to a tightly ...

Medical journals and National Comprehensive Cancer Network guidelines rarely publish FDA-identified uncertainties about new ...

The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs ...